BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release ...

Good afternoon, and thank you for joining the Inovio Fourth Quarter and Full Year 2025 Financial Results Conference Call.

City head into tonight’s Champions League Round of 16 decider against Real Madrid with a mountain to climb in order to go ...

This article was written on behalf of RADIOPUSHERS for The Source Magazine by Jonathan P. Wright, award-winning and Muck Rack–verified journalist. RADIOPUSHERS Didn’t Build An ...

Q4 2025 Earnings Call March 16, 2026 8:00 AM EDTCompany ParticipantsKristal Li - Investor Relations ManagerYan Li - Chairman, ...

A 41-year-old man flew parallel to the Earth, a guard geometry-whizzed a free throw off the rim to himself, and a Slovenian wizard buried the Nuggets in overtime.

Noel Parks - Tuohy Brothers Investment Research, Inc. Siddharth Rajeev - Fundamental Research Corp. Greetings, and welcome to the Energy Vault's Fourth Quarter 2025 Earnings Call. [Operator ...

PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

Detailed price information for Actuate Therapeutics Inc (ACTU-Q) from The Globe and Mail including charting and trades.